UnknownNCT05295277
Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort
Studying Fragile X syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bionano Genomics
- Principal Investigator
- Alka Chaubey, PhD, FACMGBionano Genomics
- Intervention
- Standard of care genetic testing group(other)
- Enrollment
- 1000 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2024
Study locations (8)
- Praxis Genomics, Atlanta, Georgia, United States
- Augusta University Research Institute, Augusta, Georgia, United States
- University of Iowa Hospitals & Clinics, Molecular Pathology, Iowa City, Iowa, United States
- Columbia University Irving Medical Center, New York, New York, United States
- DNA Microarray CGH Laboratory, Department of Pathology, University of Rochester Medical Center, West Henrietta, New York, United States
- Greenwood Genetic Center, Greenwood, South Carolina, United States
- Lineagen (A Bionano Genomics Company), Salt Lake City, Utah, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Collaborators
University of Rochester · Columbia University · Greenwood Genetic Center · Praxis Genomics · Augusta University · Medical College of Wisconsin · University of Iowa
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05295277 on ClinicalTrials.govOther trials for Fragile X syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07493096Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersHealing Hope International
- RECRUITINGPHASE2NCT07209462Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Mirum Pharmaceuticals, Inc.
- RECRUITINGNANCT06868979Optical Imaging in X-linked Disorders.Hospices Civils de Lyon
- RECRUITINGNANCT06740162Physical Activity and Community EmPOWERment ProjectUniversity of North Carolina, Chapel Hill
- RECRUITINGPHASE2NCT06081348Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersHolland Bloorview Kids Rehabilitation Hospital
- RECRUITINGNANCT06279858Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X SyndromeSpecila hospital for cerebral palsy and developmental neurology
- RECRUITINGNANCT06088589Speech-in-noise Perception in Autism and Fragile XChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT06139172Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)Rush University Medical Center